Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation

Area of Science:

• Oncology
• Cancer Research
• Radiation Biology
• Chemotherapy Resistance

Background:

• Clinical and experimental data suggest cross-resistance between cisplatin (cis-diamminedichloroplatinum(II), CDDP) and radiation resistance.
• Understanding these cross-resistance patterns is crucial for optimizing ovarian cancer treatment strategies.

Purpose of the Study:

• To investigate the existence of cross-resistance patterns between CDDP and ionizing radiation in human ovarian cancer cells.
• To determine how inducing resistance to one modality affects sensitivity to the other.

Main Methods:

• Human ovarian cancer cells were used to induce resistance to CDDP and ionizing radiation separately in a cross-over design.
• CDDP resistance was induced by culturing cells in the presence of increasing CDDP concentrations.
• Radiation resistance was induced by intermittent exposure to ionizing radiation (1.5 Gy every 48 hours for 6 months).

Main Results:

• Stable CDDP resistance (resistance factor [RF] 3.4-5.1) was associated with stable resistance to ionizing radiation (RF 1.7-2.0).
• Inducing resistance to ionizing radiation (RF 2.0) resulted in increased sensitivity to CDDP (RF 0.22-0.43), linked to enhanced platinum-DNA adduct formation.
• Both radiation resistance and CDDP sensitivity changes were unstable, disappearing after 6 months without treatment pressure.

Conclusions:

• Development of stable CDDP resistance in human ovarian cancer is linked to the development of stable resistance to ionizing radiation.
• Conversely, inducing resistance to ionizing radiation can lead to increased, albeit unstable, sensitivity to CDDP.
• These findings highlight complex interplay between different cytotoxic therapies in ovarian cancer.